These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 25220405)
1. Class I HDAC inhibition stimulates cardiac protein SUMOylation through a post-translational mechanism. Blakeslee WW; Wysoczynski CL; Fritz KS; Nyborg JK; Churchill ME; McKinsey TA Cell Signal; 2014 Dec; 26(12):2912-20. PubMed ID: 25220405 [TBL] [Abstract][Full Text] [Related]
2. A SUMO-acetyl switch in PXR biology. Cui W; Sun M; Zhang S; Shen X; Galeva N; Williams TD; Staudinger JL Biochim Biophys Acta; 2016 Sep; 1859(9):1170-1182. PubMed ID: 26883953 [TBL] [Abstract][Full Text] [Related]
3. Regulation of acetylation of histone deacetylase 2 by p300/CBP-associated factor/histone deacetylase 5 in the development of cardiac hypertrophy. Eom GH; Nam YS; Oh JG; Choe N; Min HK; Yoo EK; Kang G; Nguyen VH; Min JJ; Kim JK; Lee IK; Bassel-Duby R; Olson EN; Park WJ; Kook H Circ Res; 2014 Mar; 114(7):1133-43. PubMed ID: 24526703 [TBL] [Abstract][Full Text] [Related]
4. Analysis of Histone Deacetylases Sumoylation by Immunoprecipitation Techniques. Wagner T; Godmann M; Heinzel T Methods Mol Biol; 2017; 1510():339-351. PubMed ID: 27761833 [TBL] [Abstract][Full Text] [Related]
5. Overlapping and Divergent Actions of Structurally Distinct Histone Deacetylase Inhibitors in Cardiac Fibroblasts. Schuetze KB; Stratton MS; Blakeslee WW; Wempe MF; Wagner FF; Holson EB; Kuo YM; Andrews AJ; Gilbert TM; Hooker JM; McKinsey TA J Pharmacol Exp Ther; 2017 Apr; 361(1):140-150. PubMed ID: 28174211 [TBL] [Abstract][Full Text] [Related]
12. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes. Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of androgen receptor activity by histone deacetylase 4 through receptor SUMOylation. Yang Y; Tse AK; Li P; Ma Q; Xiang S; Nicosia SV; Seto E; Zhang X; Bai W Oncogene; 2011 May; 30(19):2207-18. PubMed ID: 21242980 [TBL] [Abstract][Full Text] [Related]
14. Class I HDACs control a JIP1-dependent pathway for kinesin-microtubule binding in cardiomyocytes. Blakeslee WW; Lin YH; Stratton MS; Tatman PD; Hu T; Ferguson BS; McKinsey TA J Mol Cell Cardiol; 2017 Nov; 112():74-82. PubMed ID: 28886967 [TBL] [Abstract][Full Text] [Related]
15. Assessing the Role of Paralog-Specific Sumoylation of HDAC1. Citro S; Chiocca S Methods Mol Biol; 2017; 1510():329-337. PubMed ID: 27761832 [TBL] [Abstract][Full Text] [Related]
16. Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy. Ferguson BS; Harrison BC; Jeong MY; Reid BG; Wempe MF; Wagner FF; Holson EB; McKinsey TA Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9806-11. PubMed ID: 23720316 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of Histone Deacetylases Induces K+ Channel Remodeling and Action Potential Prolongation in HL-1 Atrial Cardiomyocytes. Lugenbiel P; Govorov K; Rahm AK; Wieder T; Gramlich D; Syren P; Weiberg N; Seyler C; Katus HA; Thomas D Cell Physiol Biochem; 2018; 49(1):65-77. PubMed ID: 30134221 [TBL] [Abstract][Full Text] [Related]
19. Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs. Schuetze KB; McKinsey TA; Long CS J Mol Cell Cardiol; 2014 May; 70():100-7. PubMed ID: 24631770 [TBL] [Abstract][Full Text] [Related]
20. Regulation of acetylation restores proteolytic function of diseased myocardium in mouse and human. Wang D; Fang C; Zong NC; Liem DA; Cadeiras M; Scruggs SB; Yu H; Kim AK; Yang P; Deng M; Lu H; Ping P Mol Cell Proteomics; 2013 Dec; 12(12):3793-802. PubMed ID: 24037710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]